Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

R. I. Lalisang, Frans L. G. Erdkamp, C. J. Rodenburg, C. T. A. M. Knibbeler-van Rossum, J.W.R. Nortier, A. van Bochove, P. H. Th. J. Slee, E.E. Voest, J.A. Wils, J. Wals, Olaf J. L. Loosveld, A. E. M. Smals, G.H. Blijham, V. C. G. Tjan-Heijnen, H. C. Schouten

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)437-445
JournalBreast Cancer Research and Treatment
Issue number2
Publication statusPublished - Jul 2011


  • Combination chemotherapy
  • Breast neoplasm's
  • Dose-dense
  • Dose-intensive
  • Epirubicin
  • Paclitaxel

Cite this